Intelligence Platform

Patents

Browse 1,435 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8895588

Pyrazole compound

Takeda Pharmaceutical Company Limited · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8884019

Benzimidazole compound crystal

Takeda Pharmaceutical Company Limited · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883818

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883788

Fused heterocyclic ring compound

Takeda Pharmaceutical Company Limited · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871766

Heterocyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871487

Compositions, methods and uses for inducing viral growth

Takeda Vaccines, Inc. · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871273

Method for producing granules

Takeda Pharmaceutical Company Limited · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865745

Pyrazolone derivatives as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865717

Heterocyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865217

Oral preparation comprising pioglitazone

Takeda Pharmaceutical Company Limited · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8853215

Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treat

Takeda Pharmaceutical Company Limited · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846713

Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846101

Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutic

TAKEDA NYCOMED AS · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846088

Melt granulation of a composition containing a calcium-containing compound

TAKEDA NYCOMED AS · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841333

Methods for treating nephrolithiasis

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841120

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross r

Takeda Vaccines, Inc. · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8835420

Azaindole derivatives

Takeda Pharmaceutical Company Limited · Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8829189

Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

TAKEDA GMBH · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8829008

Organic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828429

Release-control composition

Takeda Pharmaceutical Company Limited · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822699

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822470

Substituted pyrido[2,3-b]pyrazines

Takeda Pharmaceutical Company Limited · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8821926

Tablet containing hardly soluble active ingredient

Takeda Pharmaceutical Company Limited · Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8816085

Methylpyrrolopyridinecarboxamides

TAKEDA GMBH · Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted